switching glp 1 agonists GLP-1 - What is it? Glucagon-like peptide-1 receptor: mechanisms and

Additionally, the study found that resmetirom was safe and well-tolerated, with no significant difference in the primary endpoint of incidence of treatment-emergent adverse events between the groups

T., Weight Gain and Quality of Life in Women Treated With Adjuvant Chemotherapy for EarlyStage Breast Cancer, Oncology Nursing Forum 28 (2001): 675684

Additionally, the findings may have limited generalizability because the Mass General Brigham population is older, less likely to have a BMI of 25 or higher, less representative of Black and Latino individuals, and less likely to have public insurance

So here are the four facts we think every woman should know about Ozempic and its cousins: Fact #1: Less than half of women find great success with GLP-1 RAs

The dose-response analysis determined an ED of 242.9 mg/kg and a maximum efficacy (E max ) of 54%, based on 1-h post-administration values [71]